These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25963090)

  • 41. Irinotecan and other agents in upper gastrointestinal and colorectal carcinomas. The University of Texas M. D. Anderson Cancer Center Investigators' Workshop, Volume 3. Introduction.
    Ajani JA
    Oncology (Williston Park); 2003 Sep; 17(9 Suppl 8):10-2. PubMed ID: 14569840
    [No Abstract]   [Full Text] [Related]  

  • 42. Maintenance therapy in metastatic colorectal cancer.
    Marshall JL
    Clin Adv Hematol Oncol; 2014 Jun; 12(6):388-90. PubMed ID: 25003569
    [No Abstract]   [Full Text] [Related]  

  • 43. [Standard therapy of CPT-11 for colorectal cancer].
    Saitoh S; Sakata Y
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1345-51. PubMed ID: 11681240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.
    Fioravanti A; Canu B; Alì G; Orlandi P; Allegrini G; Di Desidero T; Emmenegger U; Fontanini G; Danesi R; Del Tacca M; Falcone A; Bocci G
    Eur J Pharmacol; 2009 Oct; 619(1-3):8-14. PubMed ID: 19695243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Another effective chemotherapy combination for colorectal cancer.
    Oncology (Williston Park); 1988 Nov; 2(11):68. PubMed ID: 3275045
    [No Abstract]   [Full Text] [Related]  

  • 46. Progress with biological agents in metastatic colorectal cancer leads to many challenges.
    Van Cutsem E
    J Clin Oncol; 2006 Jul; 24(21):3325-7. PubMed ID: 16849745
    [No Abstract]   [Full Text] [Related]  

  • 47. Explaining the unexplainable: EGFR antibodies in colorectal cancer.
    Grothey A; Lenz HJ
    J Clin Oncol; 2012 May; 30(15):1735-7. PubMed ID: 22473160
    [No Abstract]   [Full Text] [Related]  

  • 48. S-1: another oral agent for patients with colorectal cancer.
    Benson AB
    Lancet Oncol; 2013 Dec; 14(13):1244-5. PubMed ID: 24225156
    [No Abstract]   [Full Text] [Related]  

  • 49. When less is more: maintenance therapy in colorectal cancer.
    Hubbard JM; Grothey A
    Lancet; 2015 May; 385(9980):1808-10. PubMed ID: 25862518
    [No Abstract]   [Full Text] [Related]  

  • 50. Therapeutic strategies for colorectal cancer in Europe and the United States: focus on chemotherapy for advanced colorectal cancer.
    Bennouna J; Douillard JY
    Int J Clin Oncol; 2002 Aug; 7(4):236-44. PubMed ID: 12202977
    [No Abstract]   [Full Text] [Related]  

  • 51. [New drugs for colorectal cancer: UFT].
    Frontini L
    Tumori; 2001; 87(1 Suppl 1):S57-8. PubMed ID: 11300028
    [No Abstract]   [Full Text] [Related]  

  • 52. [Problems of randomized controlled study on surgical adjuvant chemotherapy for colorectal cancer in Japan].
    Kodaira S
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2461-6. PubMed ID: 8279842
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical trials referral resource. Treatment of advanced colorectal cancer.
    Cheson BD
    Oncology (Williston Park); 1991 Apr; 5(4):61-2, 65-6, 68 passim. PubMed ID: 1831041
    [No Abstract]   [Full Text] [Related]  

  • 54. Costs of chemotherapy in the treatment of colorectal cancer.
    Jansman FG; Postma MJ
    Eur J Health Econ; 2006 Jun; 7(2):145-6. PubMed ID: 16699776
    [No Abstract]   [Full Text] [Related]  

  • 55. Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis.
    Ilic I; Jankovic S; Ilic M
    PLoS One; 2016; 11(8):e0161912. PubMed ID: 27579775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Pharmacological Costs of First-Line Therapies in Unselected Patients With Advanced Colorectal Cancer: A Review of Published Phase III Trials.
    Giuliani J; Bonetti A
    Clin Colorectal Cancer; 2016 Dec; 15(4):277-284. PubMed ID: 27521066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Chemotherapy improves prognosis in colorectal carcinoma. Soon oral therapy at home?].
    MMW Fortschr Med; 2002 Nov; 144(46):71. PubMed ID: 12534092
    [No Abstract]   [Full Text] [Related]  

  • 58. [Recent progress of chemotherapy for colorectal cancer].
    Ishiguro A; Shitara K; Munakata M; Saitoh S; Sakata Y
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2017-23. PubMed ID: 16352922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Second-line therapy in colorectal cancer.
    Berlin J
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 11):21-6. PubMed ID: 11204658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FDA approves irinotecan as first-line therapy for colorectal cancer.
    Oncology (Williston Park); 2000 May; 14(5):652, 654. PubMed ID: 10853457
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.